Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Total Non-Current Liabilities (2023 - 2025)

Historic Total Non-Current Liabilities for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $3.5 million.

  • Onconetix's Total Non-Current Liabilities fell 8328.75% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year decrease of 8328.75%. This contributed to the annual value of $18.5 million for FY2024, which is 1525.41% down from last year.
  • As of Q3 2025, Onconetix's Total Non-Current Liabilities stood at $3.5 million, which was down 8328.75% from $12.7 million recorded in Q2 2025.
  • In the past 5 years, Onconetix's Total Non-Current Liabilities ranged from a high of $21.9 million in Q4 2023 and a low of $3.5 million during Q3 2025
  • Its 3-year average for Total Non-Current Liabilities is $15.3 million, with a median of $16.4 million in 2024.
  • In the last 5 years, Onconetix's Total Non-Current Liabilities tumbled by 1525.41% in 2024 and then crashed by 8328.75% in 2025.
  • Over the past 3 years, Onconetix's Total Non-Current Liabilities (Quarter) stood at $21.9 million in 2023, then fell by 15.25% to $18.5 million in 2024, then tumbled by 81.18% to $3.5 million in 2025.
  • Its Total Non-Current Liabilities was $3.5 million in Q3 2025, compared to $12.7 million in Q2 2025 and $14.2 million in Q1 2025.